- Report
- August 2024
- 177 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- July 2024
- 161 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- July 2024
- 180 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- July 2024
- 145 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- June 2024
- 145 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- September 2022
- 120 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- January 2022
- 120 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- February 2022
- 37 Pages
Global
From €1783EUR$2,000USD£1,542GBP
- Report
- October 2021
- 293 Pages
Global
From €3967EUR$4,450USD£3,430GBP
- Report
- January 2025
- 144 Pages
Global
From €3521EUR$3,950USD£3,045GBP
- Report
- January 2025
- 144 Pages
Global
From €3521EUR$3,950USD£3,045GBP
- Report
- January 2024
- 146 Pages
Global
From €3788EUR$4,250USD£3,276GBP
- Report
- November 2023
- 140 Pages
Global
From €3967EUR$4,450USD£3,430GBP
- Report
- August 2022
- 140 Pages
Global
From €3788EUR$4,250USD£3,276GBP
- Report
- January 2025
- 191 Pages
Global
From €4452EUR$4,995USD£3,851GBP
- Report
- February 2023
- 143 Pages
North America
From €3075EUR$3,450USD£2,660GBP
- Report
- February 2023
- 146 Pages
Asia Pacific
From €3075EUR$3,450USD£2,660GBP
- Report
- February 2023
- 148 Pages
Europe
From €3075EUR$3,450USD£2,660GBP
- Report
- March 2026
- 150 Pages
Canada
From €4323EUR$4,850USD£3,739GBP
- Report
- March 2026
- 150 Pages
China
From €4323EUR$4,850USD£3,739GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more